Study
A biobank of patient-derived pediatric brain tumor models
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001002536 | Other |
Study Description
Brain tumors are the leading cause of cancer-related death in children. Genomic studies have provided insights into molecular
subgroups and oncogenic drivers of pediatric brain tumors that may lead to novel therapeutic strategies. To evaluate new
treatments, better preclinical models adequately reflecting the biological heterogeneity are needed. Through the Children’s Oncology Group ACNS02B3 study, we have generated and comprehensively characterized 30 patient-derived orthotopic
xenograft models and 7 cell lines representing 14 molecular subgroups of pediatric brain tumors. Patient-derived orthotopic
xenograft models were found to be representative of the human tumors they were derived from in terms of histology, immunohistochemistry, gene expression, DNA methylation, copy number, and mutational profiles. In vivo drug sensitivity of targeted therapeutics was associated with distinct molecular tumor subgroups and specific genetic alterations. These models and their molecular characterization provide an unprecedented resource for the cancer community to study key oncogenic drivers ... (Show More)
Study Datasets 3 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001003544 |
Whole exome sequencing data to 30 PDOX models (28 early passages, 3 late passages (1 overlap)), 3 cell lines, and 20 matching human tumors
|
Illumina HiSeq 2000,Illumina HiSeq 4000 | 53 |
| EGAD00001003545 |
Low-coverage whole genome sequencing data for 30 PDOX models (28 early passages, 4 late passages (2 overlaps)), 3 cell lines, and 21 matching human tumors
|
Illumina HiSeq 2000 | 56 |
| EGAD00001003573 |
RNA sequencing data for the PDOX model EPD-613FH
|
Illumina HiSeq 2500 | 1 |
Who archives the data?
